http://ap.tbo.com/ap/breaking/MGBXYZSRM0E.htmlWASHINGTON (AP) - A device that treats fibroids through a combination of ultrasound and magnetic resonance imaging won approval Friday from the Food and Drug Administration.
Fibroids are non-cancerous masses that occur in the uterus that can affect between 20 percent and 40 percent of women over 35. Some have no symptoms, but others experience heavy and prolonged menstrual periods, pain in the back, legs or pelvis, pressure on the bladder or bowels and pain during sexual intercourse.
The FDA said it gave expedited approval to ExAblate because it offers major advantages over other treatments for fibroids.
<snip>